BETAXOLOL

Course overview

BETAXOLOL IS A MEDICATION USED MOSTLY IN MANAGING AND TREATING OPEN-ANGLE GLAUCOMA, ESSENTIAL HYPERTENSION, POST-MYOCARDIAL INFARCTION, AND CHRONIC STABLE ANGINA. IT IS IN THE SELECTIVE BETA-1 ADRENERGIC BLOCKER CLASS OF MEDICATIONS. THIS ACTIVITY DESCRIBES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR BETAXOLOL AS A VALUABLE AGENT IN MANAGING OPEN-ANGLE GLAUCOMA AND ESSENTIAL HYPERTENSION. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE TREATMENT OF PATIENTS WITH OPEN-ANGLE GLAUCOMA, HYPERTENSION, AND RELATED CONDITIONS.